492 Results (Page 20 of 20)
US Markets Research Reports
US Brain Cancer Therapeutics Market
US Brain Cancer Therapeutics Market valued at $966 Mn in 2022, projected to reach $1,869 Mn by 2030 with a 8.6% CAGR. A significant rise in the occurrence of brain cancer, specifically glioblastoma multiforme, is expected to drive the demand for treatments in the brain cancer therapeutics market. Top leading pharmaceutical companies currently operating in the industry are Roche, Novartis, Merck, Pfizer, BMS, Bayer, Celgene, AbbVie, Teva Pharmaceuticals, and Spectrum Pharmaceuticals.
US Dental Endodontics Market Analysis
US Dental Endodontics Market was valued at $735 Mn in 2023 and is predicted to grow at a CAGR of 2.3% from 2023 to 2030, to $861.8 Mn by 2030. The key drivers of this industry include increasing emphasis on tooth preservation, rising prevalence of dental disease, aging population, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
US Breast Pump Market Report
The US Breast Pump Market was valued at $1234.8 Mn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $1931.5 Mn by 2030. The key drivers of the market include the rising female workforce, product innovations, and growing consumer awareness. The prominent players in the US Breast Pump Market are Magento Dr. Brown’s, Freemie, Evenflo, Nuk, Hygeia, Spectra Baby, Willow, Momcozy, and iAPOY, among others.
US Blood Disorder Therapeutics Market
US Blood Disorder Therapeutics Market valued at $5.628 Bn in 2022, projected to reach $8.637 Bn by 2030 with a 5.5% CAGR. The key driver of market growth is the rising demand for personalized medicine, driven by the need for individualized treatments based on genetic and molecular profiles, leading to more precise and successful therapies with minimized side effects. The US Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda Pharmaceutical, Sanofi, Novo Nordisk, Pfizer, Bayer, CSL Behring, Grifols International, Octapharma, Xenetic Biosciences, Bristol-Myers Squibb etc, among various others.
US Bone Disease Therapeutics Market
US Bone Disease Therapeutics Market valued at $6.804 Bn in 2022, projected to reach $11.603 Mn by 2030 with a 6.9% CAGR. The key drivers of this industry include the increasing aging population of the US, technological advancements, supportive economic conditions, and others. The industry is primarily dominated by players such as Amgen, Pfizer, Merck, Eli Lilly, Novartis, Bayer, and Johnson & Johnson, among others.
US Cancer Induced Bone Disease Therapeutics Market
US Cancer Induced Bone Disease Therapeutics Market valued at $546 Mn in 2022, projected to reach $736 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include an upward trend in the incidence of cancer, an expanding therapeutic landscape, treatment advancements, and others. The industry is primarily dominated by players such as Amgen, Pfizer, Merck, Medtronic, Novartis, Fresenius, and Johnson & Johnson, among others.
US Digital Biomarkers Market Analysis
US Digital Biomarkers Market was valued at $1,218 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $4,441.26 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and patient empowerment and engagement. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
US Car T-Cell Therapy Market
US Car T-Cell Therapy Market valued at $1,218 Mn in 2022, projected to reach $1,772 Mn by 2030 with a 4.8% CAGR. The rising global cancer incidence, driven by aging populations, unhealthy lifestyles, and environmental factors, fuels an expanding population eligible for CAR T-Cell therapy, contributing to the growth of its market. Currently, leading pharmaceutical companies in this market include Gilead Sciences, Novartis, Bristol Myers Squibb, Johnson & Johnson, Kite Pharma, Legend Biotech, Celgene, Cellectis, Atara Biotherapeutics, and UCAR-T.
US Congestive Heart Failure Therapeutics Market Analysis
The US Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $4.326 Bn in 2022 to $5.830 Bn by 2030, with a CAGR of 3.8% during the forecast period of 2022-2030. The key drivers of the market in the US include the increasing prevalence of risk factors, alongside rising investments in healthcare and growing initiatives for patient education and awareness, collectively fueling market expansion. The US Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, etc., among various others.
US Exosome Research Market Analysis
The US Exosome Research Market was valued at $71 Mn in 2023 and is projected to grow at a CAGR of 14% from 2023 to 2023, to $177.6 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Thermo Fisher Scientific, NanoSomix, NX Pharmagen, Malvern Instruments, Capricor Therapeutics among others.
US Physiotherapy Equipment Market Analysis
The US Physiotherapy Equipment Market was valued at $8,778 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $12,517.16 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are EMS Physio, Zynex Medical Inc., Invacare Corporation, and Baxter International among others.
US LASIK Surgery Market Analysis
US LASIK Surgery Market was valued at $1,482.60 Mn in 2023 and is predicted to grow at a CAGR of 3.21% from 2023 to 2030, to $1,849.59 Mn by 2030. The key drivers of this industry include rising prevalence, high disposable income, and medical tourism destinations. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
US Biosensors Market Analysis
The US Biosensors Market was valued at $12138 Mn in 2023 and is predicted to grow at a CAGR of 6% from 2023 to 2030, to $18251.1 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, emphasis on preventative care, and technological advancements. The prominent players of the US Biosensors Market are Masimo Corporation, Meridian Bioscience, Biosensors International, Nix Biosensors, and Abbott Laboratories, among others.
US Medical Digital Imaging System Market Analysis
The US Medical Digital Imaging System Market was valued at $12810 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $19517.35 Mn by 2030. The key drivers of this industry include the aging population, focus on preventive care, and technology advancements. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
US Hemodialysis Vascular Grafts Market Analysis
US Hemodialysis Vascular Grafts Market was valued at $87.97 Bn in 2023 and is predicted to grow at a CAGR of 3.1% from 2023 to 2030, to $108.93 Bn by 2030. The key drivers of this industry include the Rising prevalence of chronic kidney disease, the aging population, and technological advancements. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
US Breastfeeding Accessories Market Analysis
US Breastfeeding Accessories Market was valued at $1,054.20 Mn in 2023 and is predicted to grow at a CAGR of 4.80% from 2023 to 2030, to $1,463.70 Mn by 2030. The key drivers of this industry include High Breastfeeding Rates, Increasing Awareness and Education, and Technological Advancements. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
US AR/VR Medical Simulation Market Analysis
The US AR/VR medical simulation market was valued at around $0.9 Bn in 2022 and is projected to reach $2.7 Bn in 2030, with a 15.3% CAGR. The major reasons propelling the growth of this market are the increasing use of AR/VR technology in healthcare, patient safety, the growing need for top-notch medical education, and the rise in government financing for medical simulation. The market is dominated by key players like OssoVR, Surgical Theater, and CAE Healthcare.